In a bid to get easier access to “scientific workforce and institutions”, pharmaceutical giant AstraZeneca is to invest £330m in a global HQ and new drugs centre in Cambridge.
The decision will result in 700 redundancies in Cheshire. The company’s Alderley Park facility will cease operating, in a move that, the unions said, will create a skills crisis in north-west England. Linda McCulloch, Unite national officer, commented: “After 40 years of success and hundreds of millions of pounds of investment, we are at a…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
